Alendronat "Stada"
Producer: STADA Nordic
contains
Alendronat "Stada" is a medicine for bone loss. Bisphosphonate.Active substances
alendronate
Application
- Alendronate "Stada" is used for bone loss in women after menopause and in men older than 50 years if there is an increased risk of fractures.
- Also used to counteract bone barking in patients with long-term treatment with adrenal gland hormone.
Dosage
Available as tablets.
- Adults. Either 10 mg a day or 70 mg once a week.
Note:
- The tablets should be taken on an empty stomach in the morning at least 30 minutes before other food and drink, dietary supplements or medicines.
- The tablets should be swallowed whole with plenty of water (not mineral water) and should also be taken in a standing or sitting position to reduce the risk of irritation of the esophagus. Standing or seated position must be maintained for at least 30 minutes after ingestion.
possible side effects
| Very common (over 10%) | Bone pain, joint pain, muscle pain |
| Common (1-10%) | weakness Diarrhea, indigestion, constipation, intestinal gut, stomach ache, acid reflux, difficulty in swallowing, esophageal ulcer Liquid accumulation in, for example, arms and legs muscle cramps Headache, dizziness Skin condition, Hair loss |
| Uncommon (0.1-1%) | Blush Otitis in the eye |
| Rare (0.01-0.1%) | Hemorrhage or hole in the gastrointestinal tract, esophagus narrowing Fracture of bone, Decomposition of the jaw bone Severe skin reaction, Severe skin reaction where the skin is destroyed Allergic swelling of the face as well as the oral cavity and larynx, Allergic reactions |
| Very rare (less than 0.01%) | Decomposition of the bone around the ear canal |
Should not be used
Should not be used at
- hypersensitivity to bisphosphonates
- disturbances in calcium and mineral metabolism (including significant vitamin D deficiency)
- very poorly functioning kidneys
- obstructed esophagus or other conditions where the esophagus emptying is delayed.
Pregnancy
Do not use. This text differs from the company's approved product information (product summary). Not to be used. This text differs from the company's approved product information (product summary).breastfeeding
Should not be used due to lack of knowledge.Traffic
No warning.Blood donor
Do not drop. 1 day quarantine.effect
- Does bone strength increase at to inhibit the descaling of the bones.
- Binds to bone tissue, from which it is delivered to the blood very slowly (several years).
- The half life in the blood (T?) is approximately 2 hours.
Pharmaceutical forms
Tablets. 1 tablet contains 10 mg or 70 mg alendronic acid (as sodium alendronate).
Using other medicines
It is important to inform your doctor about all the medicines you are taking.
- Other medicines should not be taken concomitantly with Alendronate "Stada" as this will reduce the effect. Other medicines may be taken ? hour after Alendronat "Stada".
Grants, delivery, packages and prices
| subsidies | extradition | Dispensing form and strength | Packing | Price in kr. |
| May only be delivered once after the same prescription unless the recipient has stated on the prescription, how many times and with what time intervals additional extradition must take place | tablets 10 mg | 28 pcs (blister) | 191,50 |
| May only be delivered once after the same prescription unless the recipient has stated on the prescription, how many times and with what time intervals additional extradition must take place | tablets 10 mg | 98 pcs (blister) | 363,60 |
| May only be delivered once after the same prescription unless the recipient has stated on the prescription, how many times and with what time intervals additional extradition must take place | tablets70 mg | 14 pcs. (Blister) | 34,35 |
substitution
| tablets 70 mg |
Fosamax UetabletMSD Alendronat Alendronat "Mylan" Mylan Alendronat Alendronat "Teva" TEVA Alendronat Alendronat Bluefish Bluefish Alendronat Alendronat "Aurobindo" Orion Pharma Alendronate Alendronat "Sandoz" Sandoz Alendronat |
Doctors Advice
- ▶
Mavenclad
Manufacturer: Merck Contains Mavenclad is a medicine for the treatment of acute multiple sclerosis. Active substances Cladribin Use Mavenclad is used for very active and recurrent multiple sclerosis, where other treatment has not previously had the desired effect. The treatment is not healing, but can reduce the number and severity of seizures as well as delay disease progression.
- ▶
Locoid®
Producer: LEO Contains Locoid® is a medium-acting skin remedy with adrenal gland hormone. Active substances Hydrocortisone-17-butyrate Use Locoid® is used for various types of eczema as well as certain other skin diseases, such as psoriasis. The agent may also be used for sunburn and in some cases as an anticancer agent.
- ▶
Zavesca®
Producer: Actelion Contains Zavesca® is a drug against Gaucher's disease and Niemann-Pick's disease. Active substances Miglustat Use Zavesca® is used to treat hereditary diseases: Gaucher disease Niemann-Pick disease, both due to enzyme deficiency. May only be obtained from a hospital or specialist clinic.
- ▶
Meropenem "Fresenius Kabi"
Producer: Fresenius Kabi Contains Meropenem "Fresenius Kabi" is an antibiotic. Carbapenems. Active substances Meropenem Use Meropenem "Fresenius Kabi" is used to treat: Severe infections with bacteria that may be affected by meropenem in cases where other bactericidal agents are not effective.
